Cargando…
Anti-neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Secondary to Hydralazine: A Case Report
Hydralazine is a vasodilator used in the treatment of resistant hypertension. It is a safe and widely used antihypertensive medicine. Its common adverse effects include headache, rebound tachycardia, fluid retention, and angina. It is a rare cause of anti-neutrophil cytoplasmic antibody (ANCA) assoc...
Autores principales: | Abdullah, Ahmed, Anwar, Muhammad Saad, Ijaz, Maria, Karim, Muhammad Sikandar, Rosen, Raquel, Bokhari, Syed Rizwan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840876/ https://www.ncbi.nlm.nih.gov/pubmed/36654641 http://dx.doi.org/10.7759/cureus.32603 |
Ejemplares similares
-
Focal Alveolar Hemorrhage Secondary to Hydralazine-Associated Antineutrophilic Cytoplasmic Antibody Vasculitis
por: Martinez Manzano, Jose M, et al.
Publicado: (2023) -
Hydralazine-Induced Dual Antineutrophil Cytoplasmic Antibody Positive Vasculitis and Nephritis
por: Padala, Sandeep A, et al.
Publicado: (2020) -
Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
por: Echevarria, Victoria, et al.
Publicado: (2023) -
Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review
por: Alawneh, Diala, et al.
Publicado: (2022) -
Anti-Neutrophil Cytoplasmic Antibodies: To Care or Not to Care
por: Shahid, Sara, et al.
Publicado: (2021)